AndrewCalebHsiehMD

PubMed

• Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and ...
  Leonidas Nikolaos Diamantopoulos, Sarah K. Holt, Ali Raza Khaki, Rishi Robert Sekar, Adam J. Gadzinski, Yaw A. Nyame, Funda Vakar-Lopez, Maria S. Tretiakova, Sarah P. ...> ;Clinical Genitourinary Cancer. 2020 Oct 14
• N 6 -methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis
  Daniel A. Kuppers, Sonali Arora, Yiting Lim, Andrea R Lim, Lucas Carter, Philip Corrin, Christopher L. Plaisier, Ryan Basom, Jeffrey J. Delrow, Shiyan Wang, Housheng H...> ;Nature Communications. 2019 Oct 10
• The androgen receptor regulates a druggable translational regulon in advanced prostate cancer.
  Yuzhen Liu, Jessie L. Horn, Kalyan Banda, Asha Z. Goodman, Yiting Lim, Sujata Jana, Sonali Arora, Alexandre A. Germanos, Lexiaochuan Wen, William R. Hardin, Yu C. Yang...> ;Science Translational Medicine. 2019 Jul 31
• Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
  Brian Winters, Navonil De Sarkar, Sonali Arora, Hamid Bolouri, Sujata Jana, Funda Vakar-Lopez, Heather H. Cheng, Michael T. Schweizer, Evan Y. Yu, Petros Grivas, John ...> ;JCI insight. 2019 Jul 11
• Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations.
  Michael T. Schweizer, Emmanuel S. Antonarakis, Tarek A. Bismar, Liana B. Guedes, Heather H. Cheng, Maria S. Tretiakova, Funda Vakar-Lopez, Nola Klemfuss, Eric Q. Konni...> ;JCO precision oncology. 2019 Apr 18
• The Untranslated Regions of mRNAs in Cancer.
  Samantha L. Schuster, Andrew C. Hsieh> ;Trends in cancer. 2019 Apr 1
• Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells
  Nicola Guzzi, Maciej Cieśla, Phuong Cao Thi Ngoc, Stefan Lang, Sonali Arora, Marios Dimitriou, Kristyna Pimková, Mikael Sommarin, Roberto Munita, Michal Lubas, Yiting ...> ;Cell. 2018 May 17
• Development of a stress response therapy targeting aggressive prostate cancer
  Hao G. Nguyen, Crystal S. Conn, Yae Kye, Lingru Xue, Craig M. Forester, Janet E. Cowan, Andrew C. Hsieh, John T. Cunningham, Charles Truillet, Feven Tameire, Michael J...> ;Science Translational Medicine. 2018 May 2
• Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy
  Brian Winters, Funda Vakar-Lopez, Lisha G. Brown, Bruce Montgomery, Roland Seiler, Peter C. Black, Joost L. Boormans, Marc Dall′Era, Elai Davincioni, James Douglas, Ew...> ;Urologic Oncology-seminars and Original Investigations. 2018 Apr 12
• A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
  Laura A. Graham, Kalyan Banda, Alba Torres, Brett S. Carver, Yu Chen, Katie Pisano, Greg Shelkey, Tracy Curley, Howard I. Scher, Tamara L. Lotan, Andrew C. Hsieh, Dana...> ;Investigational New Drugs. 2018 Mar 6
• Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
  Eric G. Bluemn, Ilsa Coleman, Jared M. Lucas, Roger Coleman, Susana Hernandez-Lopez, Robin Tharakan, Daniella Bianchi-Frias, Ruth Dumpit, Arja Kaipainen, Alexandra Cor...> ;Cancer Cell. 2017 Oct 9
• Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosis
  Sujata Jana, Andrew C. Hsieh, Ramesh Gupta> ;Cell Death and Disease. 2017 Oct 5
• A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
  Xiao X. Wei, Andrew C. Hsieh, Won Seog Kim, Terence W. Friedlander, Amy M. Lin, Mirela Louttit, Charles J. Ryan> ;Oncologist. 2017 May 1
• Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
  Andrew C. Hsieh, Hao G. Nguyen, Lexiaochuan Wen, Merritt Edlind, Peter R. Carroll, Won Seog Kim, Davide Ruggero> ;Science Signaling. 2015 Nov 17
• YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.
  Christine Moore Sheridan, Tristan Grogan, Hao G. Nguyen, Colette Galet, Matthew Rettig, Andrew C. Hsieh, Davide Ruggero> ;Oncotarget. 2015 Apr 10
• PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
  Merritt Edlind, Andrew C. Hsieh> ;Asian Journal of Andrology. 2014 May 1
• Assessing gene-level translational control from ribosome profiling
  Adam B. Olshen, Andrew C. Hsieh, Craig R. Stumpf, Richard A. Olshen, Davide Ruggero, Barry S. Taylor> ;Bioinformatics. 2013 Dec 1
• The translational landscape of mTOR signalling steers cancer initiation and metastasis
  Andrew C. Hsieh, Yi Liu, Merritt Edlind, Nicholas T. Ingolia, Matthew R. Janes, Annie Sher, Evan Y. Shi, Craig R. Stumpf, Carly Christensen, Michael Bonham, Shunyou Wa...> ;Nature. 2012 May 3
• Oncogenic AKTivation of translation as a therapeutic target.
  Andrew C. Hsieh, Morgan L. Truitt, Davide Ruggero> ;British Journal of Cancer. 2011 Jul 26
• Ribosome mediated specificity in Hox mRNA translation and vertebrate tissue patterning
  Nadya Kondrashov, Aya D. Pusic, Craig R. Stumpf, Kunihiko Shimizu, Andrew C. Hsieh, Shifeng Xue, Junko Ishijima, Toshihiko Shiroishi, Maria Barna> ;Cell. 2011 Apr 29
• Targeting Eukaryotic Translation Initiation Factor 4E (eIF4E) in Cancer
  Andrew C. Hsieh, Davide Ruggero> ;Clinical Cancer Research. 2010 Oct 15
• Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
  Andrew C. Hsieh, María José Costa, Ornella Zollo, Cole Davis, Morris E. Feldman, Joseph R. Testa, Oded Meyuhas, Kevan M. Shokat, Davide Ruggero> ;Cancer Cell. 2010 Mar 16
• Novel concepts in androgen receptor blockade.
  Andrew C. Hsieh, Charles J. Ryan> ;Cancer Journal. 2008 Jan 1
• Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development
  Andrew C. Hsieh, Eric J. Small, Charles J. Ryan> ;Lancet Oncology. 2007 Oct 1
• Targeting HER proteins in cancer therapy and the role of the non-target HER3
  Andrew C. Hsieh, Mark M. Moasser> ;British Journal of Cancer. 2007 Aug 20
• Join now to see all